Interestingly, two CML samples (CML-2 and CML-4), which exhibited resistance to IM, revealed no significant (p>0.05) difference in Hes1 expression compared with the control group (Fig 4d). This evidence concerns the gene HES1 and chronic myelogenous leukemia, BCR-ABL1 positive.